Osteoporosis iIn Patients with Pemphigus Vulgaris before Steroid Therapy
Pemphigus Vulgaris (PV) is often complicated by osteoporosis. Although corticosteroid therapy undoubtedly plays a causative role, inflammation associated with PV may also contribute to osteoporosis. This study was designed to determine the prevalence of osteoporosis in patients with PV before corticosteroid therapy and to compare these findings with those reported previously in healthy volunteers. Newly diagnosed patients with PV, who had not received systemic corticosteroids, were enrolled. Bone mineral density (BMD) was measured both in the lumbar spine (L1-L4) and hip region. Data were compared with those of a healthy Iranian population. The association between the disease duration and severity and BMD was evaluated. A total of 50 patients (27 women) with a mean age of 42.6±14.5 years were enrolled. Osteoporosis was seen in 7 (14%) patients, 3 (11.1%) women, 4 (17.4%) men, and in both genders it was more common when compared to the population of healthy Iranians (8.2% in women and 4.9% in men). Osteopenia was found in 26 (52%) patients, 13 women and 13 men. Although both osteopenia and osteoporosis were more common in severe disease, neither the duration nor the severity of PV showed a statistically significant association with osteopenia or osteoporosis. The presence of a higher than expected rate of osteoporosis in patients with PV argues for osteoporosis screening and efforts aimed at prevention and early initiation of treatment to prevent unnecessary morbidity.
Veldman C, Feliciani C. Pemphigus: a complex T celldependent autoimmune disorder leading to acantholysis. Clin Rev Allergy Immunol 2008;34(3):313-20.
Shiozawa S, Kuroki Y. Osteoporosis in rheumatoid arthritis, a molecular biological aspect of connective tissuegene activation. Tohoku J Exp Med 1994;173(1):189-98.
Magaro M, Tricerri A, Piane D, et al. Generalized osteoprosis in non steroid treated rheumatoid arthritis. Rheumatol Int 1991;11(2):73-6.
Gough AK, Lilley J, Eyre S, et al. Generalized bone loss in patient with early rheumatoid arthritis. Lancet 1994; 344(8914): 23-7.
Celiker R, Gökçe-Kutsal Y, Cindas A, et al. Osteoprosis in rheumatoid arthritis. Effect of disease activity. Clin rheumatol 1995;14(4): 429-33.
Yuen SY, Rochwerg B, Ouimet J, et al. Patients with scleroderma may have increased risk of osteoprosis. A comparision to rheumatoid arthritis and non inflammatory musculoskeletal conditions. J Rheumatol 2008;35(6):1073-8.
Di Munno O, Mazzantini M, Massei P, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with calcinosis. Clin Rheumatol 1995;14(4):407-12.
Nicholson GC, Moseley JM, Sexton PM, et al. Abundant calcitonion receptors in isolated rat osteoclats. Biochemical and autoradiographic characterization. J Clin Invest 1986;78(2):355-60.
Calasis E. Interleukin-1 has independent effects on deoxyribonrcleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 1986;118(1):74-81.
Collins DA, Chambers TJ. Prostagladin E2 Promotes osteoclats formation in murine hematopoietics cultures through an action on hematopoietic cells. J Bone Miner Res 1992;7(5):555-61.
Gowen M, Wood DD, Ihrie EJ, et al. An interleukin -1 like factor stimulates bone resportion in vitro. Nature 1983; 306: 378-80.
Pfeilschifter J, Chenu C, Bird A, et al. Interleukin -1 and tumor necrosis Factor Stimulate the Formation of human osteoclastice cells in vitro. J Bone Miner Res 1989; 4:113-8.
Bertolini DR, Nedwin GE, Bringman TS, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis Factors. Nature 1986; 319(6053): 516-8.
Ota N, Nakajima T, Nakazawa I, et al. A nucleotide variant in the promoter region of the interleukin - 6 gene associated with decreased bone mineral density. J Hum Genet 2001;46(5):267-72.
Bystryn J, Steinman N. The adjuvant therapy of pemphigus. Arch dermatol 1996;132(2): 203-12.
Herbst A, Bystryn JC. Patterns of remission in Pemphigus vulgaris. J Am Acad Dermatol 2000;42(3):422-7.
Kawner J, Dhar S. Factors responsible for death in patients with Pemphigus. J Dermatol 1994;21(9):655-9.
Razzaque- Ahmed A, Moy R. Death in Pemphigus. J Am Acad Dermatol 1982;7(2):221-8.
Savin J, Burg S. Corticosteroids and death in Pemphigus. J Am Acad Dermatol 1983;9:725.
Wohl Y, Dreiher J, Cohen AD. Pemphigus and osteoporosis: a case-control study. Arch dermatol 2010;146(10):1126-31.
Lindsay R, Cosman F. Osteoporosis. In: E. Braunwald , Dennis- L.Kasper, editors. Harrison`s Principles of Internal Medicine. 17th ed. New York, NY: Mc Graw-Hill; 2008: p. 2397-407.
Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H, et al. Risks factors for low bone mineral density in premenopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol 2009;28(1):65-70.
Rodrı´guez-Bores L, Barahona-Garrido J, Yamamoto- Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol 2007;13(46):6156-65.
Schmidt S, Mellström D, Norjavaara E, et al. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population- based study from western Sweden. Inflamm Bowel Dis 2009;15(12):1844-50.
Mounach A, Ouzzif Z, Wariaghli G, et al. Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab 2008;26(4):379-84.
Stellon AJ, Davies A, Compston J, et al. Bone loss in autoimmune chronic active hepatitis on maintenance glucocorticosteroid therapy. Gastroenterology 1985;89(5):1078-83.
Konishi M, Takahashi K, Yoshimoto E, et al. Association between osteopenia/osteoporosis and the serum RANKL in HIV-infected patients. AIDS 2005;19(11):1240-1.
Dreiher J, Weitzman D, Cohen AD. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 2009;129(7):1643-9.
Akbarian M, Davatchi F, Salimzadeh A, et al. Bone mass density in the normal population of Iran. APLAR J Rheumatol 2005;8(3):177-83.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.